Next Article in Journal
Intake of Non-Nutritive Sweeteners in Chilean Children after Enforcement of a New Food Labeling Law that Regulates Added Sugar Content in Processed Foods
Previous Article in Journal
Antidiabetic Effects of Flavan-3-ols and Their Microbial Metabolites
Previous Article in Special Issue
Heat-Killed Bifidobacterium breve B-3 Enhances Muscle Functions: Possible Involvement of Increases in Muscle Mass and Mitochondrial Biogenesis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Nutraceuticals and Nutrition Supplements: Challenges and Opportunities

by
Rafat A. Siddiqui
1,* and
Mohammed H. Moghadasian
2,3
1
Food Chemistry and Nutrition Science Laboratory, Agricultural Research Station, Virginia State University, Petersburg, VA 23806, USA
2
Department of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, MB R3T 2N2, Canada
3
Canadian Center for Agri-food Research in Health and Medicine, St. Boniface Hospital Research Center, Winnipeg, MB R2H 2A6, Canada
*
Author to whom correspondence should be addressed.
Nutrients 2020, 12(6), 1593; https://doi.org/10.3390/nu12061593
Submission received: 26 May 2020 / Accepted: 27 May 2020 / Published: 29 May 2020
(This article belongs to the Special Issue Nutraceutical, Nutrition Supplements and Human Health)
The term “nutraceuticals” is derived from “nutrition” and “pharmaceuticals” and is used for nutrition products that are also used as medicine [1]. “Nutraceuticals” often contain modified/unmodified whole food, plant extracts alone or in combination, semipurified and purified phytochemicals, or a combination of different phytochemicals. On the other hand, nutritional supplements are nutritional compounds that supplement one’s diet by increasing one’s total daily intake. Nutritional supplements also contain substances alone or in combination with vitamins and minerals, with or without other herbal products, with or without zoochemicals (creatinine, glucosamine, melatonin, bee pollens) and with or without probiotics.
Nutraceuticals and nutrition supplements are collectively referred to as “dietary supplements,” intended to be taken orally [2]. The use of supplements is suggested to (but may not claim to) diagnose, cure, mitigate, treat, or prevent diseases. Often, background information suggests that they are intended to affect the structure or function of the body [3]. However, they do not undergo premarket approval. The common reasons for using dietary supplements are to improve conditions such as overall health and disease prevention, performance (athletics, sports, sex, etc.) and appearance (weight loss, sex appeal) [4]. These are often perceived as “safe” and less likely to have side effects. The scientific research on nutraceuticals and nutrition supplements is frequently misinterpreted or overstretched for commercial interests because of high consumer demands. The manufacturing and marketing of supplements are full of challenges.
Several challenges associated with the development of nutraceuticals are often ignored because of a lack of authoritative control. These challenges include identification of the authentic source of raw materials, purity of the compound, presence of other active compounds, quality, lack of experimental evidence, false advertising, contamination with heavy metals, and interactions between supplements and drugs. For example, a common herb “ginseng” has several varieties [5] such as California ginseng, wild ginseng, prickly ginseng, Pacific ginseng, Malaysian ginseng, Indian ginseng, Peruvian ginseng, Southern ginseng, Brazilian ginseng, and wild-red ginseng. All of these are sold as ginseng, but none of these belongs to the genus Panax, which contains real ginseng including Korean ginseng (P. ginseng), South China ginseng (P. notoginseng) and American ginseng (P. quinquefolius). Some varieties of star anise have several hundred-fold anisatin, a neurotoxin, that the authentic star anise (Illicium verum) has [6]. The supplements that are not prepared under strict GMP conditions may have unintentional contamination [7], including microbes (pathogens/nonpathogens), pesticides, mycotoxin (aflatoxin), heavy metals (seaweeds), zinc (cadmium), and calcium (lead). In addition, some supplements such as those commonly used for weight loss, body building, and sex enhancement are spiked with prohibited drugs to improve efficacy [8]. Some manufacturers also try to use a closely related herb, which may or may not have the active ingredients. For example, goldenseal (Hydrastis canadensis), used for berberine/hydrastine content, is often substituted with goldthread (Coptis chinensis) or Oregon grape (Mahonia aquifolium), which may have low or no berberine/hydrastine [9].
Besides, maintaining the quality of nutraceuticals is another challenge, as phytochemistry is inherently variable due to seasonal and geographical variations [10]. It is challenging to measure and maintain consistency in finished products and limit undesirable constituents. Interaction of herbal supplements with medicinal drugs is also a big concern [11]. For example, St. John’s wort (Hypericum perforaum) is used as an effective antidepressant, but it also activates several cytochrome P450 isoenzymes, which make a large number of medicinal drugs ineffective [12,13]. Among all the major concerns for using the nutraceuticals is the lack of scientific evidence [14]. Some are never tested under properly controlled experimental conditions, and unlike pharmaceuticals, most nutraceuticals do not undergo “randomized controlled clinical studies.”
The purpose of this Special Issue on “Nutraceuticals, Nutrition Supplements, and Human Health” is to comprehensively review the data from basic and clinical research to discuss the benefits as well as potential adverse effects of “functional food-derived” products. We have invited international experts, researchers and authors to submit original research and review articles that address the progress and our current understanding of nutraceuticals/supplements from in vitro and in vivo studies, as well as from clinical trials describing the benefits/adverse effects with underlying mechanisms. This Special Issue presents a compendium of excellent laboratory and clinical studies using plant extracts [15,16,17,18,19,20], purified compounds [21,22,23], modified formulations [22,24], and probiotics [25,26,27,28] to improve many health conditions, including metabolic disorders [17,20], cardiovascular disease [29], muscle metabolism [18,25], obesity [16,17,20], neurological disorders [30], infectious diseases [26,27], aging [23], and cancers [18,21,24,31].
This Special Issue’s overall goal is to present readers with high-quality scientific evidence for the use of dietary supplements, nutraceuticals, and functional foods that can be appropriately used to improve health parameters in various stages of one’s lifecycle. We thank all the contributors for their contributions and for their dedication to making a difference in human health with low-cost remedies.

Author Contributions

R.A.S. and M.H.M. equally contributed in the preparation of this editorial. All authors have read and agreed to the published version of the manuscript.

Funding

None.

Acknowledgments

The authors greatly acknowledge the contribution of all authors for this Special Issue.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kalra, E.K. Nutraceutical-definition and introduction. AAPS Pharm. Sci. 2003, 5, 27–28. [Google Scholar] [CrossRef] [Green Version]
  2. US National Institutes of Health. Dietary Supplements: Background Information; Office of Dietary Supplements, US National Institutes of Health: Bethesda, MD, USA, 2011.
  3. FDA. Small Entity Compliance Guide on Structure/Function Claims; Docket Number: FDA-2013-S-0610; Center for Food Safety and Applied Nutrition: College Park, MD, USA, 2002.
  4. Dickinson, A.; Blatman, J.; El-Dash, N.; Franco, J.C. Consumer usage and reasons for using dietary supplements: Report of a series of surveys. J Am. Coll. Nutr. 2014, 33, 176–182. [Google Scholar] [CrossRef] [PubMed]
  5. Foster, S. Towards an understanding of ginseng adulteration: The tangled web of names, history, trade, and perception. HerbalGram 2016, 3, 36–57. [Google Scholar]
  6. Mathon, C.; Bongard, B.; Duret, M.; Ortelli, D.; Christen, P.; Bieri, S. Analysis of the neurotoxin anisatin in star anise by LC-MS/MS. Food Addit. Contam. Part A 2013, 30, 1598–1605. [Google Scholar] [CrossRef] [PubMed]
  7. Costa, J.G.; Vidovic, B.; Saraiva, N.; Do Céu Costa, M.; Favero, G.D.; Marko, D.; Oliveira, N.G.; Fernandes, A.S. Contaminants: A dark side of food supplements? Free Radic. Res. 2019, 53, 1113–1135. [Google Scholar] [CrossRef]
  8. Mathews, N.M. Prohibited contaminants in dietary supplements. Sports Health 2018, 10, 19–30. [Google Scholar] [CrossRef]
  9. Edwards, D.J.; Draper, E.J. Variations in alkaloid content of herbal products containing goldenseal. J. Am. Pharm. Assoc. 2003, 43, 419–423. [Google Scholar]
  10. Dhami, N.; Mishr, A.D. Phytochemical variation: How to resolve the quality controversies of herbal medicinal products? J. Herb. Med. 2015, 5, 118–127. [Google Scholar]
  11. Brazier, N.C.; Levine, M.A.H. Drug-herb interaction among commonly used conventional medicines: A compendium for health care professionals. Am. J. Ther. 2003, 10, 163–169. [Google Scholar]
  12. Mills, E.; Montori, V.M.; Wu, P.; Gallicano, K.; Clarke, M.; Guyatt, G. Interaction of St John’s wort with conventional drugs: Systematic review of clinical trials. Br. Med. J. 2004, 329, 27. [Google Scholar]
  13. Henderson, L.; Yue, Q.Y.; Bergquist, C.; Gerden, B.; Arlett, P. St John’s wort (Hypericum perforatum): Drug interactions and clinical outcomes. Br. J. Clin. Pharmacol. 2002, 54, 349–356. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Santini, A.; Cammarata, A.M.; Capone, G.; Ianaro, A.; Tenore, G.C.; Pani, L.; Novellino, E. Nutraceuticals: Opening the debate for a regulatory framework. Br. J. Clin. Pharmacol. 2018, 84, 659–672. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Santiago-Saenz, Y.O.; Monroy-Torres, R.; Rocha-Amador, D.O.; Hernández-Fuentes, A.D. Effect of a supplementation with two quelites on urinary excretion of arsenic in adolescents exposed to water contaminated with the metalloid in a community in the state of guanajuato, Mexico. Nutrients 2020, 12, 98. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Kim, Y.J.; Kwon, E.Y.; Kim, J.W.; Lee, Y.; Ryu, R.; Yun, J.; Kim, M.; Choi, M.S. Intervention study on the efficacy and safety of platycodon grandiflorus ethanol extract in overweight or moderately obese adults: A single-center, randomized, double-blind, placebo-controlled trial. Nutrients 2019, 11, 2445. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Sasso, S.; Sampaio e Souza, P.C.; Santana, L.F.; Cardoso, C.A.L.; Alves, F.M.; Portugal, L.C.; De Faria, B.B.; Da Silva, A.F.; Motta-Castro, A.R.C.; Soares, L.S.; et al. Use of an extract of annona muricata linn to prevent high-fat diet induced metabolic disorders in C57BL/6 Mice. Nutrients 2019, 11, 1509. [Google Scholar] [CrossRef] [Green Version]
  18. Alsolmei, F.A.; Li, H.; Pereira, S.L.; Krishnan, P.; Johns, P.W.; Siddiqui, R.A. Polyphenol-enriched plum extract enhances myotubule formation and anabolism while attenuating colon cancer-induced cellular damage in C2C12 Cells. Nutrients 2019, 11, 1077. [Google Scholar] [CrossRef] [Green Version]
  19. Gurley, B.J.; Miousse, I.R.; Nookaew, I.; Ewing, L.E.; Skinner, C.M.; Jenjaroenpun, P.; Wongsurawat, T.; Kennon-McGill, S.; Avula, B.; Bae, J.Y.; et al. Decaffeinated green tea extract does not elicit hepatotoxic effects and modulates the gut microbiome in lean B6C3F1 mice. Nutrients 2019, 11, 776. [Google Scholar] [CrossRef] [Green Version]
  20. Santana, L.F.; Inada, A.C.; Espirito Santo, B.L.S.; Filiú, W.F.O.; Pott, A.; Alves, F.M.; Guimarães, R.C.A.; Freitas, K.C.; Hiane, P.A. Nutraceutical potential of carica papaya in metabolic syndrome. Nutrients 2019, 11, 1608. [Google Scholar] [CrossRef] [Green Version]
  21. Schmiech, M.; Lang, S.J.; Ulrich, J.; Werner, K.; Rashan, L.J.; Syrovets, T.; Simmet, T. Comparative investigation of frankincense nutraceuticals: Correlation of boswellic and lupeolic acid contents with cytokine release inhibition and toxicity against triple-negative breast cancer cells. Nutrients 2019, 11, 2341. [Google Scholar] [CrossRef] [Green Version]
  22. Martucci, A.; Reurean-Pintilei, D.; Manole, A. Bioavailability and sustained plasma concentrations of CoQ10 in healthy volunteers by a novel oral timed-release preparation. Nutrients 2019, 11, 527. [Google Scholar] [CrossRef] [Green Version]
  23. Simes, D.C.; Viegas, C.S.B.; Araújo, N.; Marreiros, C. Vitamin K as a diet supplement with impact in human health: Current evidence in age-related diseases. Nutrients 2020, 12, 138. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Liao, S.C.; Hsu, W.H.; Huang, Z.Y.; Chuang, K.L.; Lin, K.T.; Tseng, C.L.; Tsai, T.H.; Dao, A.H.; Su, C.L.; Huang, C.Y.F. Bioactivity evaluation of a novel formulated curcumin. Nutrients 2019, 11, 2982. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Toda, K.; Yamauchi, Y.; Tanaka, A.; Kuhara, T.; Odamaki, T.; Yoshimoto, S.; Xiao, J.Z. Heat-killed bifidobacterium breve B-3 Enhances Muscle Functions: Possible involvement of increases in muscle mass and mitochondrial biogenesis. Nutrients 2020, 12, 219. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Martín, V.; Cárdenas, N.; Ocaña, S.; Marín, M.; Arroyo, R.; Beltrán, D.; Badiola, C.; Fernández, L.; Rodríguez, J.M. Rectal and vaginal eradication of streptococcus agalactiae (GBS) in pregnant women by using lactobacillus salivarius CECT 9145, a target-specific probiotic strain. Nutrients 2019, 11, 810. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Cárdenas, N.; Martín, V.; Arroyo, R.; López, M.; Carrera, M.; Badiola, C.; Jiménez, E.; Rodríguez, J.M. Prevention of recurrent acute otitis media in children through the use of lactobacillus salivarius PS7, a target-specific probiotic strain. Nutrients 2019, 11, 376. [Google Scholar] [CrossRef] [Green Version]
  28. Wong, C.B.; Iwabuchi, N.; Xiao, J.Z. Exploring the science behind bifidobacterium breve M-16V in infant health. Nutrients 2019, 11, 1724. [Google Scholar] [CrossRef] [Green Version]
  29. Moghadasian, M.H.; Kaur, R.; Kostal, K.; Joshi, A.A.; Molaei, M.; Le, K.; Fischer, G.; Bonomini, F.; Favero, G.; Rezzani, R.; et al. Anti-atherosclerotic properties of wild rice in low-density lipoprotein receptor knockout mice: The gut microbiome, cytokines, and metabolomics study. Nutrients 2019, 11, 2894. [Google Scholar]
  30. Trudeau, M.S.; Madden, R.F.; Parnell, J.A.; Gibbard, W.B.; Shearer, J. Dietary and supplement-based complementary and alternative medicine use in pediatric autism spectrum disorder. Nutrients 2019, 11, 1783. [Google Scholar]
  31. Allaoui, A.; Gascón, S.; Benomar, S.; Quero, J.; Osada, J.; Nasri, M.; Rodríguez-Yoldi, M.J.; Boualga, A. Protein hydrolysates from fenugreek (trigonella foenum graecum) as nutraceutical molecules in colon cancer treatment. Nutrients 2019, 11, 724. [Google Scholar] [CrossRef] [Green Version]

Share and Cite

MDPI and ACS Style

Siddiqui, R.A.; Moghadasian, M.H. Nutraceuticals and Nutrition Supplements: Challenges and Opportunities. Nutrients 2020, 12, 1593. https://doi.org/10.3390/nu12061593

AMA Style

Siddiqui RA, Moghadasian MH. Nutraceuticals and Nutrition Supplements: Challenges and Opportunities. Nutrients. 2020; 12(6):1593. https://doi.org/10.3390/nu12061593

Chicago/Turabian Style

Siddiqui, Rafat A., and Mohammed H. Moghadasian. 2020. "Nutraceuticals and Nutrition Supplements: Challenges and Opportunities" Nutrients 12, no. 6: 1593. https://doi.org/10.3390/nu12061593

APA Style

Siddiqui, R. A., & Moghadasian, M. H. (2020). Nutraceuticals and Nutrition Supplements: Challenges and Opportunities. Nutrients, 12(6), 1593. https://doi.org/10.3390/nu12061593

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop